Initial Clinical Experience with Helical Tomotherapy for Head and Neck Cancer
Overview
Authors
Affiliations
Background: To report a single-institutional experience with the use of helical tomotherapy (HT)-based intensity-modulated radiotherapy (IMRT) for head and neck cancer.
Methods: Seventy-seven consecutive patients were treated with HT for squamous cell carcinoma of the head and neck to a median dose of 66 Gy (range, 60 to 72 Gy). Megavoltage CT scans were obtained as part of an image-guided registration protocol for patient alignment before each treatment. Concurrent chemotherapy was administered to 48 patients (62%).
Results: The 2-year estimates of overall survival, local-regional control, and disease-free survival were 82%, 77%, and 71%, respectively. Spatial evaluation of local-regional failures revealed that 16 of the 18 patients who progressed in the primary site or neck failed in the high-dose planning target volume (PTV).
Conclusions: HT appears to achieve clinical outcomes comparable to contemporary series reporting on IMRT for head and neck cancer.
Chitapanarux I, Nobnop W, Sripan P, Chumachote A, Tharavichitkul E, Chakrabandhu S Radiol Oncol. 2017; 51(3):351-356.
PMID: 28959172 PMC: 5612000. DOI: 10.1515/raon-2017-0017.
Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.
Du L, Zhang X, Ma L, Feng L, Li F, Zhou G Biomed Res Int. 2014; 2014:980767.
PMID: 25114932 PMC: 4119915. DOI: 10.1155/2014/980767.
Chen A, Daly M, Cui J, Wooten H, Farwell D, Purdy J Br J Radiol. 2014; 87(1040):20130697.
PMID: 24884726 PMC: 4112398. DOI: 10.1259/bjr.20130697.
A novel setup approach for helical tomotherapy in head and neck cancer: A case report.
Duma M, Geinitz H, Kampfer S, Kesting M Oncol Lett. 2013; 6(5):1470-1474.
PMID: 24179543 PMC: 3813675. DOI: 10.3892/ol.2013.1558.
Kong M, Hong S, Choi J, Kim Y Radiat Oncol J. 2013; 31(1):1-11.
PMID: 23620863 PMC: 3633225. DOI: 10.3857/roj.2013.31.1.1.